Expression-linked promoter selection (ELiPS) engineers short, strong ubiquitous promoters for gene therapy applications
Sydney V. Oraskovich, Kazuomori K. Lewis, Joost van Haasteren, Hyun‐Cheol Lee, Esther Chu, David V. Schaffer
ELiPS generates and screens short, strong promoters for gene therapy, outperforming existing promoters in vitro and enabling therapeutic expression in vivo.
bioRxiv · Jun 26, 2026 · PreprintBioengineering